Insider · CIK 0002043500
Adam Pelavin
Files at ORGS (Orgenesis Inc.). First filing -, latest -.
Adam Pelavin files SEC Form 4 as director at ORGS (Orgenesis Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Adam Pelavin has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 12, 2024 | ORGS Orgenesis Inc. | AGrant or award Stock Optionderivative | +625 | $0.00 | $0 | 625 | Dec 16, 2024 |
| Dec 12, 2024 | ORGS Orgenesis Inc. | AGrant or award Stock Optionderivative | +1,250 | $0.00 | $0 | 1,250 | Dec 16, 2024 |
Questions about Adam Pelavin
Answered from the filings on this page, as of the latest one.
Is Adam Pelavin buying or selling?
Adam Pelavin has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Adam Pelavin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Adam Pelavin has 0.
Where does Adam Pelavin file Form 4?
Adam Pelavin has filed Form 4 at ORGS (Orgenesis Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.